1,submitted drug The has hope researchers the already been FDA the Agency Medicines approval available that it could be use patients US 2017 
2,submitted drug The has available could in Europe been FDA both Agency European developed Amgen the be patients US year next approved if soon afterwards the Medicines company 
3,results regulator EU expected is drug looking Agency European deliver to is trial the Medicines verdict its T-Vec year later initial this 
